| Period Ending | Mar 30, 2013 | Dec 30, 2012 | Sep 29, 2012 | Jun 29, 2012 |
|---|
|
Total Revenue
|
417
|
380
|
3,478
|
599
| | Cost of Revenue |
-
|
-
|
-
|
-
| | |
Gross Profit
|
417
|
380
|
3,478
|
599
| |
|
Operating Expenses |
|
Research Development | 4,430 | 4,901 | 4,400 | 4,472 |
|
Selling General and Administrative | 2,151 | 2,298 | 1,485 | 1,556 |
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | | |
Operating Income or Loss
|
(6,164)
|
(6,819)
|
(2,407)
|
(5,429)
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 41 | 9 | 5 | 10 |
|
Earnings Before Interest And Taxes | (6,123) | (6,810) | (2,402) | (5,419) |
|
Interest Expense |
-
|
-
|
-
|
-
|
|
Income Before Tax | (6,123) | (6,810) | (2,402) | (5,419) |
|
Income Tax Expense |
-
|
-
|
-
|
-
|
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | (6,123) | (6,810) | (2,402) | (5,419) | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
(6,123)
|
(6,810)
|
(2,402)
|
(5,419)
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
(6,123)
|
(6,810)
|
(2,402)
|
(5,419)
|
|
0.38(2.06%) 3:14PM EDT - Nasdaq Real Time Price